全球敗血症診斷市場

全球敗血症診斷市場預計到2030年將達到12億美元

全球敗血症診斷市場規模在2024年估計為7.454億美元，預計到2030年將達到12億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為7.5%。本報告分析的細分市場之一—微生物技術，預計將以9.1%的複合年成長率成長，並在分析期結束時達到7.498億美元。免疫檢測技術細分市場預計在分析期間將以4.8%的複合年成長率成長。

美國市場規模估計為1.933億美元，而中國市場預計將以12.8%的複合年成長率成長。

據估計，2024年美國敗血症診斷市場規模將達1.933億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到2.994億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到12.8%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到3.0%和7.5%。在歐洲，德國的複合年成長率預計將達到約3.9%。

全球膿毒症診斷市場—主要趨勢和促進因素概述

為什麼對先進膿毒症診斷的需求成長如此迅速

膿毒症是一種危及生命的疾病，由機體對感染疾病的過度反應引起，至今仍是全球主要死因之一。早期發現和及時介入對於改善患者預後和降低醫療成本至關重要，因此，對先進敗血症診斷方法的需求正在迅速成長。傳統診斷方法在早期識別敗血症方面常常面臨時間延遲、準確性不足和複雜性等挑戰。為此，醫院和臨床檢查室正擴大採用創新診斷方案，包括分子診斷、快速抗原檢測和基於生物標記的檢測，以實現膿毒症的準確快速診斷。敗血症的高發生率，尤其是在加護病房（ICU）和急診科，進一步推動了這些先進診斷工具在全球的應用。

技術進步對敗血症診斷有何影響？

技術進步顯著改善了敗血症的診斷現狀，提高了診斷的準確性、速度和可靠性。分子診斷技術的創新，包括聚合酵素鏈鎖反應(PCR) 和次世代定序(NGS)，能夠快速識別病原體及其抗生素抗藥性譜，從而促進標靶治療。此外，自動化平台和照護現場(POC) 設備的開發使診斷更貼近臨床，縮短了結果獲取時間，並改善了臨床決策。人工智慧和機器學習演算法也被整合到診斷工具中，用於分析複雜的資料集，並更準確地預測敗血症的預後。此外，基於生物標記的檢測，例如抑鈣素(PCT)、C 反應蛋白 (CRP) 和乳酸水平，為臨床醫生提供了關於膿毒症嚴重程度和進展的關鍵資訊，推動了先進診斷市場的擴張。

哪些細分市場正在推動膿毒症診斷技術的應用？

敗血症診斷市場按技術、產品類型、病原體、檢測類型、最終用戶和地區進行細分。關鍵技術包括分子診斷、免疫檢測、微生物學和流式細胞技術，其中分子診斷因其快速且準確的病原體鑑定能力主導地位。產品類型涵蓋儀器、試劑、軟體和服務，其中試劑和耗材由於持續的需求而佔據最大佔有率。敗血症診斷的目標病原體包括細菌、真菌和病毒。由於臨床環境中細菌感染疾病的高發生率，細菌性敗血症診斷最為常見。敗血症診斷的最終使用者包括醫院、病理檢查室和研究機構。由於加護病房(ICU) 和急診科的膿毒症病例數量眾多，醫院在市場中佔據主導地位。按地區分類，北美和歐洲是領先的市場，這得益於其先進的醫療保健基礎設施和較高的健康意識。同時，由於醫療保健投資的增加和對敗血症意識的提高，亞太地區正在崛起成為一個高成長地區。

敗血症診斷市場成長的關鍵促進因素是什麼？

敗血症診斷市場的成長受多種因素驅動，包括敗血症盛行率的上升、對快速且準確診斷工具的需求以及分子和生物標記診斷技術的進步。照護現場設備和自動化平台的開發，能夠提供快速且高靈敏度的檢測結果，正在推動醫院和診斷檢查室對這些產品的市場應用。人們對個人化醫療和標靶治療的日益關注，也促進了能夠精確識別病原體和進行抗生素敏感性測試的先進敗血症診斷方法的應用。政府為降低敗血症死亡率和提高早期檢測率而推出的各項主導和醫療保健計劃，為市場成長創造了新的機會。此外，對新型膿毒症生物標記、基於人工智慧的診斷工具和快速多重檢測方法的研發投入不斷增加，也進一步推動了市場擴張。

部分：

依技術（微生物學、免疫檢測、分子診斷、其他技術）、依產品（血液培養基、檢測試劑盒及試劑、設備、軟體）、依檢測類型（檢查室、照護現場）

受訪公司範例

• Abbott Diagnostics
• Axis-Shield Diagnostics Ltd
• Becton, Dickinson and Company
• bioMerieux SA
• Bruker Corporation
• Cytosorbents Corporation
• Danaher Corporation
• EKF Diagnostics Holdings PLC
• Immunexpress Inc.
• Luminex Corporation
• Mitsubishi Chemical Europe
• Response Biomedical Corp.
• Roche Diagnostics（Schweiz）AG
• T2 Biosystems
• Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用典型的 LLM 或產業專用的SLM 方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 澳洲
• 印度
• 韓國
• 亞太其他地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Sepsis Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for Sepsis Diagnostics estimated at US$745.4 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis period. Growth in the Immunoassay Technology segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$193.3 Million While China is Forecast to Grow at 12.8% CAGR

The Sepsis Diagnostics market in the U.S. is estimated at US$193.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$299.4 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Sepsis Diagnostics Market - Key Trends and Drivers Summarized

Why Is the Demand for Advanced Sepsis Diagnostics Growing Rapidly?

Sepsis, a life-threatening condition resulting from the body’s extreme response to infection, remains a leading cause of mortality worldwide. The demand for advanced sepsis diagnostics is rapidly increasing due to the need for early detection and timely intervention, which are critical for improving patient outcomes and reducing healthcare costs. Traditional diagnostic methods often face challenges related to time delays, accuracy, and the complexity of identifying sepsis at an early stage. In response, hospitals and clinical laboratories are increasingly adopting innovative diagnostic solutions, such as molecular diagnostics, rapid antigen tests, and biomarker-based assays, to enable precise and swift diagnosis of sepsis. The high prevalence of sepsis, particularly in intensive care units (ICUs) and emergency departments, is further driving the adoption of these advanced diagnostic tools globally.

How Are Technological Advancements Impacting Sepsis Diagnostics?

Technological advancements are significantly enhancing the sepsis diagnostics landscape, offering greater accuracy, speed, and reliability. Innovations in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), are enabling rapid identification of pathogens and their antibiotic resistance profiles, facilitating targeted therapy. Additionally, the development of automated platforms and point-of-care (POC) devices is bringing diagnostic capabilities closer to the bedside, reducing the time-to-results and improving clinical decision-making. AI and machine learning algorithms are also being integrated into diagnostic tools to analyze complex datasets and predict sepsis outcomes more accurately. Furthermore, the rise of biomarker-based tests, such as procalcitonin (PCT), C-reactive protein (CRP), and lactate levels, is providing clinicians with critical information on the severity and progression of sepsis, driving the market for advanced diagnostics.

Which Market Segments Are Leading the Adoption of Sepsis Diagnostics?

The sepsis diagnostics market is segmented by technology, product type, pathogen, testing type, end-user, and region. Key technologies include molecular diagnostics, immunoassays, microbiology, and flow cytometry, with molecular diagnostics leading due to their rapid and precise pathogen identification capabilities. Product types range from instruments and reagents to software and services, with reagents and consumables accounting for the largest share owing to their recurring demand. Pathogens covered in sepsis diagnostics include bacterial, fungal, and viral pathogens, with bacterial sepsis diagnostics being the most common due to the high incidence of bacterial infections in clinical settings. End-users of sepsis diagnostics include hospitals, pathology labs, and research institutes, with hospitals dominating the market due to the high volume of sepsis cases in ICUs and emergency departments. Geographically, North America and Europe are the leading markets due to advanced healthcare infrastructure and high awareness, while Asia-Pacific is emerging as a high-growth region driven by increasing healthcare investments and rising sepsis awareness.

What Are the Key Drivers of Growth in the Sepsis Diagnostics Market?

The growth in the sepsis diagnostics market is driven by several factors, including the increasing prevalence of sepsis, the need for rapid and accurate diagnostic tools, and advancements in molecular and biomarker-based diagnostics. The development of point-of-care devices and automated platforms that provide quick turnaround times and high sensitivity is driving market adoption across hospitals and diagnostic labs. The growing focus on personalized medicine and targeted therapies is expanding the use of advanced sepsis diagnostics that enable precise pathogen identification and antibiotic susceptibility testing. The rise of government initiatives and healthcare programs aimed at reducing sepsis mortality rates and improving early detection is creating new opportunities for market growth. Additionally, the increasing investments in R&D for novel sepsis biomarkers, AI-based diagnostic tools, and rapid multiplex assays are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Sepsis Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Microbiology, Immunoassay, Molecular Diagnostic, Other Technologies); Product (Blood Culture Media, Assay Kits & Reagents, Instruments, Software); Testing Type (Laboratory, Point-of-Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

• Abbott Diagnostics
• Axis-Shield Diagnostics Ltd
• Becton, Dickinson and Company
• bioMerieux SA
• Bruker Corporation
• Cytosorbents Corporation
• Danaher Corporation
• EKF Diagnostics Holdings PLC
• Immunexpress Inc.
• Luminex Corporation
• Mitsubishi Chemical Europe
• Response Biomedical Corp.
• Roche Diagnostics (Schweiz) AG
• T2 Biosystems
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Sepsis Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Sepsis Cases Globally Spurs Demand for Advanced Diagnostic Solutions
  • Technological Advancements in Molecular Diagnostics Propel Innovation in Sepsis Testing
  • Increasing Focus on Early Detection and Rapid Diagnosis Expands Addressable Market Opportunity
  • Growth of Point-of-Care Testing (POCT) for Sepsis Strengthens Business Case for Diagnostic Tools
  • Focus on Enhancing Sensitivity and Specificity of Sepsis Diagnostic Tests Drives Adoption
  • Emergence of Automated and AI-Driven Diagnostic Systems Generates New Market Opportunities
  • Rising Use of Biomarker-Based Diagnostics in Sepsis Detection Boosts Market Potential
  • Shift Towards Personalized Medicine and Targeted Therapies Expands Market Reach
  • Growing Emphasis on Sepsis Management in Critical Care Units Spurs Market Innovation
  • Emergence of Sepsis Diagnostics as a Key Component in Antimicrobial Stewardship Programs Expands Adoption
  • Expansion of Diagnostic Applications in Low- and Middle-Income Countries Creates New Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sepsis Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Molecular Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Blood Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Assay Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Point-of-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• JAPAN
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• CHINA
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• EUROPE
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• FRANCE
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• GERMANY
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• INDIA
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030
• AFRICA
  • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2015, 2025 & 2030

IV. COMPETITION